Use of law molecular weight dextran for prevention of thrombosis in surgical patients (review of the literature)
Sukhanov, A.A.; Sukhanov, V.A.
Khirurgiia 1976(10): 133-135
1976
ISSN/ISBN: 0023-1207 PMID: 1022932 Document Number: 104910
Document emailed within 1 workday
Related Documents
Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399Vecsey, D.; Bánkuti, P. 1974: Prevention of Thrombosis. Results in urologic surgery using lower molecular dextran Die Medizinische Welt 25(5): 198-200
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340
Hull, R.D.; Pineo, G.F.; Stein, P.D.; Mah, A.F.; MacIsaac, S.M.; Dahl, O.E.; Ghali, W.A.; Butcher, M.S.; Brant, R.F.; Bergqvist, D.; Hamulyák, K.; Francis, C.W.; Marder, V.J.; Raskob, G.E. 2001: Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review Archives of Internal Medicine 161(16): 1952-1960
Jørgensen, L.N.; Wille-Jørgensen, P.A.; Hauch, O. 1994: Prevention of postoperative thrombosis with low-molecular-weight heparins Ugeskrift for Laeger 156(39): 5667-5672
Haas, S. 1995: Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis Deutsche Medizinische Wochenschrift 120(14): 503
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
Koppenhagen, K.; Tröster, E.; Matthes, M.; Häring, R. 1990: Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1163-1166
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Yang, Z.; Liu, X.; Dai, S.; Liu, K.; Zhang, Y.; Sun, J.; Yin, X. 2010: Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(9): 1058-1061
Lamy, O.; Cornuz, J.; Yersin, B. 1999: Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review Schweizerische Medizinische Wochenschrift 129(18): 707-714
Uzan, A.; Clairefond, P.; Mardiguian, J.; Trillou, M.; Le Fur, G.; Mestre, M. 1985: Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169) Annales Pharmaceutiques Francaises 43(6): 539-546
Turpie, A.G.; Levine, M.N.; Hirsh, J.; Carter, C.J.; Jay, R.M.; Powers, P.J.; Andrew, M.; Magnani, H.N.; Hull, R.D.; Gent, M. 1987: Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke Lancet 1(8532): 523-526
Borsand, M.A. 1977: Heparin and prevention of postoperative thrombosis: a review of the literature and a suggested protocol Journal of the American Osteopathic Association 76(5): 356-359
Wang, H.W. 1973: Low molecular weight dextran im epidemic hemorrhagic fever Zhonghua Yi Xue Za Zhi 6: 355-358
Brossy, J.J.; Lewis, J.; Black, D. 1982: Low-molecular-weight dextran and puff-adder bites South African Medical Journal 62(11): 349-350
Kawiak, W.; Pilarczyk, M.; Jarosz, M.; Gieracz-Nazar, A. 1987: Effect of low-molecular-weight dextran (40,000) on the levels of inorganic phosphorus and lipid-bound phosphorus in the blood of patients with a transient disorder of cerebral circulation Wiadomosci Lekarskie 40(16): 1088-1093
Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Matsuo, O.; Kawaguchi, T.; Kosugi, T.; Mihara, H. 1980: Effect of low molecular weight dextran sulphate on plasmin activity measured with S-2251 Acta Physiologica Latino Americana 30(3): 193-198
Rossberg, G.; Krüger, E.C. 1977: The treatment of sudden deafness and Menière's disease with papaverin and low molecular weight dextran Laryngologie Rhinologie Otologie 56(2): 160-166